Discovery of a potent and selective c-Kit inhibitor for the treatment of inflammatory diseases

Abstract A potent and selective c-Kit inhibitor 20 was identified through a structure–activity relationship study. In an in vivo mouse model of mast cell activation, 20 blocked the SCF-induced histamine release with an EC 50 of 26 nM.